查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2017211

膽道支架市場：2026-2032年全球市場預測（依產品類型、適應症、手術類型、最終用戶和通路分類）

Biliary Stent Market by Product Type, Indication, Procedure Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，膽道支架市場價值將達到 1.4843 億美元，到 2026 年將成長至 1.5771 億美元，到 2032 年將達到 2.3432 億美元，年複合成長率為 6.73%。

主要市場統計數據
基準年 2025 1.4843億美元
預計年份：2026年 1.5771億美元
預測年份 2032 2.3432億美元
複合年成長率 (%) 6.73%

對現代膽道支架領域進行全面概述，重點介紹臨床因素、器械發展、手術注意事項和相關人員的優先事項。

膽道支架的現狀融合了微創癌症治療、介入放射學和內視鏡技術的創新，因此需要對其進行介紹，以引導相關人員了解其不斷發展的臨床、營運和商業性趨勢。近年來，這項技術已從有限的工具集發展成為一個擁有多種差異化器械設計的平台，這些設計全面影響臨床醫生的選擇，涵蓋了金屬和聚合物材料、塗層策略和輸送系統等方面的差異。同時，良性和惡性膽道阻塞患者群體正在老化，合併症也日益增多，因此，維持通暢性通暢、便於再次介入和控制感染變得癒發重要。

臨床實踐、技術和醫療保健服務的變革性變化正在重塑膽道支架的創新、手術選擇以及在所有醫療保健環境中以價值主導的部署。

膽道支架領域正經歷一場變革，臨床和商業性因素的共同推動這項變革，重塑器材研發和應用的路徑。技術進步不再局限於漸進式改進，而是轉向更具針對性的工程解決方案。覆膜和裸金屬支架正在不斷改進，以應對腫瘤侵襲和支架移位問題；自擴張式和球囊擴張型支架的創新設計則最佳化了在彎曲解剖結構中的置入精度。材料科學的進步，包括塗層和生物可吸收材料的應用，為延長器械使用壽命和降低慢性併發症的發生率提供了途徑。伴隨這些技術變革，手術流程也經皮。內視鏡逆行性造影（ERCP）作為支架置入的主要入路，其重要性日益凸顯；而當解剖結構或先前手術史需要其他策略時，經皮介入手術則作為輔助手段。

對美國於 2025 年推出的關稅如何推動整個價值鏈的供應鏈轉型、籌資策略和國內製造業投資進行全面分析。

美國2025年實施的關稅對膽道支架生態系統產生了多方面的影響，涵蓋採購到產品開發的各個環節。關稅帶來的成本壓力迫使供應商和醫療系統重新思考籌資策略，並加速供應鏈多元化。以往採購主要集中在少數國際製造地，現在各機構正在探索近岸外包、多源採購和策略性庫存規劃等方式來降低風險。對製造商而言，關稅環境正在重塑其資本配置決策。對本地製造能力、模具以及國內生產線監管支援的投資，正與在岸生產相關的更高固定成本進行權衡。

深入了解將醫療設備設計、臨床適應症、治療途徑、臨床環境和通路與商業化和臨床導入策略聯繫起來的關鍵細分領域。

市場區隔洞察揭示了器材選擇和治療路徑如何因產品架構、臨床適應症、治療途徑、醫療機構和分銷策略的不同而有所差異，這些因素對於制定商業化和臨床部署計劃都至關重要。按產品類型分類，市場包括金屬支架和塑膠支架。在金屬支架中，塗層金屬支架和非塗層金屬支架是主要類型，其中塗層支架又可細分為全塗層金屬支架和部分塗層金屬支架，而非塗層金屬支架則分為球囊擴張型和自擴張式金屬支架。這種產品層面的細分對於臨床醫生選擇器械至關重要，他們需要在移位風險、抗腫瘤侵襲性、徑向支撐力和複雜狹窄的輸送能力之間取得平衡。性能上的權衡會影響採購決策，並決定器械在醫院處方集和競標回應中的定位。

從深入的區域觀點揭示了美洲、歐洲、中東和非洲以及亞太地區的法律規範、醫療保健服務模式和採購實踐的差異。

區域趨勢對監管預期、採購偏好和臨床實踐模式有顯著影響，因此，地理洞察對於策略規劃至關重要。在美洲，醫療機構越來越重視具有明確報銷途徑和在住院及門診環境中均能體現價值的實證醫療器材。臨床醫生正在利用內視鏡和經皮技術的結合，採購部門也正在採用綜合競標程序。歐洲、中東和非洲地區情況高度多樣化，先進的三級醫療機構推動了技術先進支架的早期應用，而其他市場則優先考慮價格可負擔性、供應鏈可靠性和區域監管協調，以促進跨境准入。該地區監管方面的細微差異和不同的支付模式要求制定靈活的臨床和商業策略，以適應業務量大的專科機構和資源有限的環境。

一份策略競爭考察，詳細闡述了臨床證據、綜合服務和有針對性的創新如何塑造膽道支架領域的領導地位和差異化優勢。

膽道支架領域的競爭動態由成熟的醫療設備製造商、專業的介入治療公司以及專注於材料、塗層和輸送系統的新興創新者共同構成​​。行業領導企業在採購評估中脫穎而出，強調整合的價值提案，包括可靠的臨床證據、針對特定手術的培訓以及全生命週期支持。隨著企業越來越重視上市後數據收集和真實世界數據，以證明產品的長期臨床耐久性和降低再次干預的需求，能夠提供註冊登記、監測分析和結果儀錶板的公司在基於價值的談判中更具優勢。

為高階主管提供切實可行的、有影響力的建議，以協調臨床證據、價值鏈韌性和價值主導的商業化，加速推廣應用，並降低採購風險。

產業領導者應優先採取一系列切實可行的措施，將臨床潛力轉化為永續的商業性成果，同時應對供應鏈和採購方面的挑戰。首先，投資於有針對性的臨床證據項目，將醫療設備的性能與以患者為中心的療效和醫療保健系統成本因素聯繫起來，確保試驗設計和註冊登記能夠涵蓋支付方和採購委員會重視的指標。其次，制定靈活的生產和採購策略，降低單一來源風險和關稅風險，包括近岸採購選項和分級供應商模式，以穩定供應和籌資策略。第三，建立全面的價值主張，簡化部署流程並展現整體擁有成本 (TCO) 優勢，​​包括臨床醫生培訓、手術支援和上市後療效提案。

我們採用嚴謹的混合方法調查方法，結合對臨床醫生的訪談、二手資料的整合以及專家檢驗，以提供可靠且可操作的見解。

本分析所依據的研究採用了一種三角測量法，結合了原始調查、二手資料整合和專家檢驗，以確保研究結果的穩健性和實用性。原始資料包括對執業內視鏡醫師、介入放射科醫師、採購經理和醫院管理人員的結構化訪談，旨在了解設備選擇、手術流程和合約偏好等方面的實際決策因素。二級資訊來源包括同行評審的臨床文獻、監管文件、臨床試驗註冊資訊以及公開的醫療政策和報銷文件，用於分析臨床和監管趨勢。這些資訊被整合起來，以揭示技術特性與臨床路徑和採購行為之間的關係。

一項權威的綜合分析，重點闡述了臨床創新、循證一致性和供應鏈適應性如何全面決定不斷發展的膽道支架生態系統的成功。

總之，膽道支架市場正日趨成熟，成為一個更為複雜的生態系統，其中器械差異化、手術選擇和籌資策略相互作用，共同決定臨床和商業性的成功。金屬和聚合物設計的創新、塗層和非塗層結構的改進以及輸送系統的增強，正在拓展臨床醫生的選擇範圍，並改善患者照護路徑。同時，諸如醫保報銷重點的變化、區域監管的複雜性以及近期關稅等外部壓力，迫使製造商和醫療服務提供者採取更具韌性、以循證醫學為基礎的方法。這些趨勢有利於那些能夠證明切實臨床效益、提供一體化手術支援並維持供應鏈柔軟性的機構。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：膽道支架市場：依產品類型分類

  • 金屬支架
    • 塗層金屬支架
      • 全塗層金屬支架
      • 部分覆膜金屬支架
    • 未塗層金屬支架
      • 球囊擴張型金屬支架
      • 自膨式金屬支架
  • 塑膠支架

第9章：膽道支架市場：依適應症分類

  • 良性閉塞
  • 惡性阻塞

第10章：依治療類型分類的膽道支架市場

  • 內視鏡逆行性胰造影
  • 經皮經肝膽造影

第11章 膽道支架市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 膽道支架市場：依通路分類

  • 直接競標
  • 銷售代理

第13章：膽道支架市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：膽道支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 膽道支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國膽道支架市場

第17章：中國膽道支架市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • Leufen Medical GmbH
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Olympus Corporation
  • Taewoong Medical Co., Ltd.
Product Code: MRR-035DA3C6371F

The Biliary Stent Market was valued at USD 148.43 million in 2025 and is projected to grow to USD 157.71 million in 2026, with a CAGR of 6.73%, reaching USD 234.32 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 148.43 million
Estimated Year [2026] USD 157.71 million
Forecast Year [2032] USD 234.32 million
CAGR (%) 6.73%

A comprehensive introduction to the contemporary biliary stent environment clarifying clinical drivers, device evolution, procedural considerations, and stakeholder priorities

The biliary stent landscape sits at the intersection of minimally invasive oncology care, interventional radiology, and endoscopic innovation, and requires an introduction that orients stakeholders to evolving clinical, operational, and commercial dynamics. Recent years have seen the technology migrate from a narrow toolset to a platform of differentiated device designs, including variations in metal and polymer materials, covering strategies, and delivery systems that collectively shape clinician choice. At the same time, patient populations presenting with both benign and malignant biliary obstruction are aging and presenting with greater comorbidity, which elevates the priority of durable patency, ease of reintervention, and infection control.

Consequently, procurement teams and clinical leaders must balance competing priorities: device performance under complex anatomies, procedural efficiency during endoscopic retrograde cholangiopancreatography workflows, and cost containment pressures across care settings. These forces are amplified by an increasingly complex reimbursement and regulatory environment that favors evidence demonstrating clinical benefit and cost-effectiveness. Therefore, any foundational understanding of the field must emphasize how device characteristics align with procedural choices and patient trajectories, and how manufacturers, providers, and payers each influence adoption patterns through evidence generation, supply chain strategies, and value-based contracting.

Transformative clinical, technological, and care-delivery shifts reshaping biliary stent innovation, procedural choice, and value-driven adoption across care settings

The biliary stent arena is undergoing transformative shifts driven by converging clinical and commercial catalysts that are reshaping device development and adoption pathways. Technological advances are moving beyond incremental improvements to focused engineering solutions: covered and uncovered metal stents have been refined to address tumor ingrowth and migration, while innovations in self-expanding and balloon-expandable designs optimize deployment accuracy in tortuous anatomies. Advances in materials science, including coatings and bioresorbable concepts, are expanding device lifecycles and offering pathways to reduce chronic complication rates. These technological shifts are being matched by procedural evolution, with endoscopic retrograde cholangiopancreatography increasingly serving as the primary access route for stent placement, complemented by percutaneous approaches when anatomies or prior surgeries dictate alternative strategies.

Concurrently, service delivery models are transforming; procedures are migrating toward ambulatory surgical centers where appropriate, supported by streamlined peri-procedural pathways and enhanced anesthesia protocols to reduce length of stay. Regulatory scrutiny and payer emphasis on real-world outcomes are incentivizing manufacturers to produce robust clinical data and post-market surveillance to demonstrate long-term patency and safety. As a result, strategic differentiation is now hinged on integrated value propositions that combine device performance, procedural support, and data-generation capabilities. These shifts collectively make the market more dynamic, with innovation cycles increasingly focused on delivering measurable clinical and economic improvements across diverse healthcare settings.

Comprehensive analysis of how United States tariffs introduced in 2025 are catalyzing supply chain shifts, procurement strategies, and domestic manufacturing investments across the value chain

The introduction of United States tariffs in 2025 has introduced a multifaceted set of implications for the biliary stent ecosystem that extend from procurement to product development. Tariff-related cost pressures have prompted suppliers and health systems to re-evaluate sourcing strategies and to accelerate supply chain diversification. Where sourcing was previously concentrated in a limited set of international manufacturing hubs, organizations are now considering near-shoring, multi-sourcing, and strategic inventory planning to mitigate exposure. For manufacturers, the tariff environment is reshaping capital allocation decisions: investments in local manufacturing capabilities, tooling, and regulatory support for domestically produced lines are being weighed against the higher fixed costs of onshore production.

These dynamics also influence channel behavior and contracting. Hospitals and ambulatory centers are more carefully negotiating long-term supply agreements and revisiting direct tender strategies and distributor partnerships to secure price stability and guaranteed access. At the clinical level, there is an emphasis on devices that reduce the need for repeat interventions and emergency readmissions, since total procedure and follow-up costs are under increased scrutiny by purchasing committees. In sum, the tariffs function as a catalyst for structural change, accelerating moves toward supply chain resilience, procurement sophistication, and a sharpened focus on devices that demonstrably lower overall care burden and resource utilization.

Key segmentation insights that connect device design, clinical indication, procedural route, care setting, and distribution pathways to commercialization and clinical adoption strategies

Segmentation insights reveal how device choice and care pathways vary according to product architecture, clinical indication, procedural route, care setting, and distribution strategy, each of which informs commercialization and clinical integration plans. Based on Product Type, the landscape encompasses Metal Stent and Plastic Stent options; within Metal Stent, Covered Metal Stent and Uncovered Metal Stent variants predominate, with Covered Metal Stent further delineated into Fully Covered Metal Stent and Partially Covered Metal Stent, while Uncovered Metal Stent divides into Balloon Expanding Metal Stent and Self Expanding Metal Stent. This product granularity matters for clinicians selecting devices that balance migration risk, tumor ingrowth resistance, radial force, and deliverability for complex strictures. Performance trade-offs drive procurement decisions and shape device positioning in hospital formularies and tender responses.

Based on Indication, treatment pathways bifurcate between Benign Obstruction and Malignant Obstruction, with benign etiologies placing higher emphasis on removability and long-term patency without provoking tissue hyperplasia, and malignant presentations prioritizing durable palliation, resistance to tumor ingrowth, and compatibility with adjunct oncologic therapies. Based on Procedure Type, clinical teams choose between Endoscopic Retrograde Cholangiopancreatography and Percutaneous Transhepatic Cholangiography depending on anatomy, prior surgical history, and institutional expertise, which in turn affects device selection and training requirements. Based on End User, adoption patterns differ among Ambulatory Surgical Centers, Hospitals, and Specialty Clinics as each setting imposes distinct volume thresholds, reimbursement rules, and workflow constraints. Finally, Based on Distribution Channel, procurement pathways flow through Direct Tender and Distributors, influencing pricing dynamics, post-sale support, and the availability of bundled services such as training and clinical data packages. Together, these segmentation lenses provide a structured framework for targeting R&D investments, clinical evidence generation, and commercial go-to-market strategies that reflect the specific needs of clinicians and purchasers.

Deep regional perspectives that illuminate how regulatory frameworks, care delivery models, and procurement behaviors vary across the Americas, Europe Middle East & Africa, and Asia-Pacific regions

Regional dynamics exert a profound influence on regulatory expectations, procurement preferences, and clinical practice patterns, making geographic insights essential for strategic planning. In the Americas, institutions increasingly prioritize evidence-backed devices with clear pathways for reimbursement and value demonstration in both hospital and ambulatory settings; clinicians leverage a mix of endoscopic and percutaneous techniques and purchasing bodies employ consolidated tender processes. Europe, Middle East & Africa present wide heterogeneity, with pockets of advanced tertiary centers driving early adoption of technically sophisticated stents while other markets emphasize affordability, supply chain reliability, and regional regulatory harmonization to facilitate cross-border access. Regulatory nuance and divergent payer models in this region require adaptable clinical and commercial strategies that accommodate both high-volume specialist centers and resource-constrained environments.

In the Asia-Pacific region, rapid expansion of procedural capacity, growing cancer incidence, and strategic investments in interventional infrastructure are accelerating demand for both established metal and innovative polymer-based stents. This region also demonstrates strong local manufacturing capabilities and an appetite for cost-effective solutions that can be scaled across diverse care settings. Across all regions, manufacturers must reconcile global device portfolios with localized evidence generation, supply chain structures, and training initiatives to ensure consistent clinical outcomes and sustainable market access. Understanding these regional contours enables targeted investments in regulatory filings, clinical collaborations, and distribution partnerships that align with regional procurement behavior and clinician preferences.

Strategic competitive insights detailing how clinical evidence, integrated services, and targeted innovation are shaping leadership and differentiation in the biliary stent sector

Competitive dynamics in the biliary stent field are shaped by a mix of established device manufacturers, specialized interventional companies, and emerging innovators focused on materials, coatings, and delivery systems. Industry leaders emphasize integrated value propositions that combine robust clinical evidence, procedure-specific training, and lifecycle support to differentiate in procurement evaluations. There is increasing strategic emphasis on post-market data collection and real-world evidence to demonstrate clinical longevity and reduced need for reintervention, and those firms that can offer registries, surveillance analytics, and outcome dashboards gain advantage in value-based negotiations.

Smaller and niche players tend to compete on focused innovations-improved radial force, anti-migration geometries, or bioactive coatings-that address specific clinical pain points. Partnerships between device makers and clinical networks are becoming more common to accelerate evidence generation and to support guideline inclusion. Additionally, strategic alliances with distributors and service partners extend reach into lower-volume centers and ambulatory settings where bundled service offerings and local training can materially increase uptake. Overall, competitive success hinges on the ability to align technical differentiation with reproducible clinical outcomes and scalable commercial models that respond to procurement channels and procedural trends.

Practical, high-impact recommendations for executives to align clinical evidence, supply chain resilience, and value-driven commercialization to accelerate adoption and reduce procurement risk

Industry leaders should prioritize a set of actionable steps to translate clinical promise into durable commercial performance while addressing supply chain and procurement challenges. First, invest in targeted clinical evidence programs that map device performance to patient-centered outcomes and health system cost drivers, ensuring that trial designs and registries capture metrics valued by payers and purchasing committees. Second, develop flexible manufacturing and sourcing strategies that reduce exposure to single-source risks and tariffs, including near-shore options and tiered supplier models to stabilize supply and pricing. Third, create bundled value propositions that include clinician training, procedural support, and post-market outcome tracking to simplify adoption and demonstrate total cost-of-care benefits.

Furthermore, commercial teams should refine segmentation-aligned go-to-market approaches that tailor messaging and service models to differences across product types, indications, procedure types, end users, and distribution channels. Engage with regional stakeholders early to harmonize regulatory pathways and reimbursement dossiers, and pursue partnerships with health systems to pilot value-based contracting where appropriate. Finally, prioritize ease-of-use in device design and invest in digital tools that support procedural planning and follow-up, thereby reducing variability in clinical outcomes and strengthening the case for widespread adoption.

A rigorous mixed-methods research methodology combining clinician interviews, secondary evidence synthesis, and expert validation to provide reliable and actionable insights

The research underpinning this analysis employed a triangulated methodology combining primary engagements, secondary data synthesis, and expert validation to ensure robustness and practical relevance. Primary inputs included structured interviews with practicing endoscopists, interventional radiologists, procurement leaders, and hospital administrators to capture real-world decision drivers around device selection, procedure workflows, and contracting preferences. Secondary sources comprised peer-reviewed clinical literature, regulatory filings, clinical trial registries, and publicly available health policy and reimbursement documents to contextualize clinical trends and regulatory dynamics. These inputs were synthesized to map technology attributes against clinical pathways and procurement behaviors.

To enhance reliability, findings were subjected to expert panel review with senior clinicians and supply chain specialists who validated thematic conclusions and highlighted regional nuances. Data assimilation prioritized consistency across sources and transparent documentation of assumptions and limitations. Where gaps persisted, sensitivity checks and scenario analyses were used to explore alternative interpretations. Limitations include variability in reporting standards across geographies and the evolving nature of tariffs and regulatory decisions; nonetheless, the mixed-methods approach provides actionable intelligence grounded in clinical practice and commercial realities.

A conclusive synthesis emphasizing how clinical innovation, evidence alignment, and supply chain adaptability collectively determine success in the evolving biliary stent ecosystem

In conclusion, the biliary stent landscape is maturing into a more sophisticated ecosystem where device differentiation, procedural choice, and procurement strategy interact to determine clinical and commercial success. Innovations in metal and polymer designs, refinements in covered versus uncovered configurations, and improvements in delivery systems are expanding clinician options and improving patient care pathways. At the same time, external pressures such as evolving reimbursement priorities, regional regulatory complexity, and recent tariff-driven supply chain recalibrations are compelling manufacturers and providers to adopt more resilient and evidence-driven approaches. These trends favor organizations that can demonstrate tangible clinical benefits, offer integrated procedural support, and maintain supply chain flexibility.

As stakeholders navigate this evolving environment, alignment between clinical evidence, commercial strategy, and operational execution will be essential. Manufacturers that invest in targeted clinical programs, adaptable sourcing, and value-oriented commercial models will be well positioned to meet the needs of diverse care settings-from high-volume tertiary centers to ambulatory surgical environments-and to support clinicians in delivering consistent, high-quality outcomes for patients with biliary obstruction.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biliary Stent Market, by Product Type

  • 8.1. Metal Stent
    • 8.1.1. Covered Metal Stent
      • 8.1.1.1. Fully Covered Metal Stent
      • 8.1.1.2. Partially Covered Metal Stent
    • 8.1.2. Uncovered Metal Stent
      • 8.1.2.1. Balloon Expanding Metal Stent
      • 8.1.2.2. Self Expanding Metal Stent
  • 8.2. Plastic Stent

9. Biliary Stent Market, by Indication

  • 9.1. Benign Obstruction
  • 9.2. Malignant Obstruction

10. Biliary Stent Market, by Procedure Type

  • 10.1. Endoscopic Retrograde Cholangiopancreatography
  • 10.2. Percutaneous Transhepatic Cholangiography

11. Biliary Stent Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Biliary Stent Market, by Distribution Channel

  • 12.1. Direct Tender
  • 12.2. Distributors

13. Biliary Stent Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biliary Stent Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biliary Stent Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Biliary Stent Market

17. China Biliary Stent Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. Becton, Dickinson and Company
  • 18.7. Boston Scientific Corporation
  • 18.8. CONMED Corporation
  • 18.9. Cook Medical LLC
  • 18.10. Leufen Medical GmbH
  • 18.11. Medtronic plc
  • 18.12. Merit Medical Systems, Inc.
  • 18.13. Nipro Corporation
  • 18.14. Olympus Corporation
  • 18.15. Taewoong Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BILIARY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BILIARY STENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BILIARY STENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BILIARY STENT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BILIARY STENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BILIARY STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BILIARY STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BILIARY STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BILIARY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BILIARY STENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BILIARY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BILIARY STENT MARKET SIZE, BY METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BILIARY STENT MARKET SIZE, BY METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BILIARY STENT MARKET SIZE, BY METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BILIARY STENT MARKET SIZE, BY FULLY COVERED METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BILIARY STENT MARKET SIZE, BY FULLY COVERED METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BILIARY STENT MARKET SIZE, BY FULLY COVERED METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BILIARY STENT MARKET SIZE, BY PARTIALLY COVERED METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BILIARY STENT MARKET SIZE, BY PARTIALLY COVERED METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BILIARY STENT MARKET SIZE, BY PARTIALLY COVERED METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BILIARY STENT MARKET SIZE, BY BALLOON EXPANDING METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BILIARY STENT MARKET SIZE, BY BALLOON EXPANDING METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BILIARY STENT MARKET SIZE, BY BALLOON EXPANDING METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BILIARY STENT MARKET SIZE, BY SELF EXPANDING METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BILIARY STENT MARKET SIZE, BY SELF EXPANDING METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BILIARY STENT MARKET SIZE, BY SELF EXPANDING METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BILIARY STENT MARKET SIZE, BY PLASTIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BILIARY STENT MARKET SIZE, BY PLASTIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BILIARY STENT MARKET SIZE, BY PLASTIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BILIARY STENT MARKET SIZE, BY BENIGN OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BILIARY STENT MARKET SIZE, BY BENIGN OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BILIARY STENT MARKET SIZE, BY BENIGN OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BILIARY STENT MARKET SIZE, BY MALIGNANT OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BILIARY STENT MARKET SIZE, BY MALIGNANT OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BILIARY STENT MARKET SIZE, BY MALIGNANT OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BILIARY STENT MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BILIARY STENT MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BILIARY STENT MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BILIARY STENT MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BILIARY STENT MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BILIARY STENT MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BILIARY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BILIARY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BILIARY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BILIARY STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BILIARY STENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BILIARY STENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BILIARY STENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BILIARY STENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BILIARY STENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BILIARY STENT MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BILIARY STENT MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BILIARY STENT MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BILIARY STENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BILIARY STENT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BILIARY STENT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BILIARY STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS BILIARY STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BILIARY STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. GCC BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 147. GCC BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 148. GCC BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. G7 BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 175. G7 BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 176. G7 BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. G7 BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. NATO BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 183. NATO BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 184. NATO BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 185. NATO BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 186. NATO BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL BILIARY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BILIARY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BILIARY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA BILIARY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA BILIARY STENT MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA BILIARY STENT MARKET SIZE, BY COVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA BILIARY STENT MARKET SIZE, BY UNCOVERED METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA BILIARY STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA BILIARY STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA BILIARY STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA BILIARY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)